Evotec SE ( EVOTF) - Stock Earnings
EVOTF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026 AfterMarket | — / — | — | — / — | — |
EVOTF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -50.6 million USD | 192.3 million USD |
| 2025Q4 | 17.2 million USD | 297.3 million USD |
| 2026Q1 | -140.3 million USD | 180.2 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
EVOTF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -92.8 million USD | 863.8 million USD |
| 2024 | -204.2 million USD | 829.9 million USD |
| 2025 | -121.5 million USD | 925.2 million USD |
| 2026 Est. | — | — |
EVOTF
Price: $6.69
52 week price:
Earnings Per Share: -1.28 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.2 billion